AffiELISA® Anti M2 Cholinergic Receptor Autoantibodies
affielisa
$747.5
AffiADA® Trastuzumab (Herceptin) Immunogenicity ELISA
Specifications
Technique
ADA
Description
Trastuzumab (Herceptin® ) is a humanized recombinant monoclonal antibody used for the treatment of primary breast cancers overexpressing human epidermal growth factor 2 (HER2). HER2 protein is overexpressed in 25-30% of breast cancers.
Additional Attributes
Technique
ADA
Brand
AffiADA